New estimates from the World Health Organization (WHO) show a significant increase in the number of countries moving toward malaria elimination, with prevention efforts saving millions of dollars in healthcare costs over the past 14 years in many African countries.
According to the World Malaria Report 2015, released today, more than half (57) of the 106 countries with malaria in 2000 had achieved reductions in new malaria cases of at least 75 percent by 2015. In that same time frame, 18 countries reduced their malaria cases by 50 percent to 75 percent.
Across sub-Saharan Africa, the prevention of new cases of malaria has resulted in major cost savings for endemic countries. New estimates presented in the WHO report show that reductions in malaria cases attributable to malaria control activities saved an estimated $900 million in case management costs in the region between 2001 and 2014. Insecticide-treated mosquito nets contributed the largest savings, followed by artemisinin-based combination therapies and indoor residual spraying.
“Since the start of this century, investments in malaria prevention and treatment have averted more than 6 million deaths,” says Dr. Margaret Chan, WHO director-general. “We know what works. The challenge now is to do even more.”
For the first time since WHO began keeping score, the European Region is reporting zero indigenous cases of malaria. This achievement was made possible through strong country-level leadership, technical support from WHO and financial assistance from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Since 2000, the malaria mortality rate has declined by 85 percent in the South-East Asia Region, by 72 percent in the Region of the Americas, by 65 percent in the Western Pacific Region, and by 64 percent in the Eastern Mediterranean Region. While the African Region continues to carry the highest malaria burden, here too there have been impressive gains: over the last 15 years, malaria mortality rates fell by 66 percet among all age groups, and by 71 percent among children under 5, a population particularly susceptible to the disease.
Country-level and regional progress in malaria control is reflected in global disease trends. Since 2000, malaria incidence and death rates have fallen by 37 percent and 60 percent, respectively, around the world. Among children under five, malaria death rates have declined by 65 percent. An estimated 6.2 million deaths have been averted since 2000.
According to the report, Target 6C of the Millennium Development Goals-which aimed to halt and reverse the global incidence of malaria between 2000 and 2015-has been achieved. Substantial progress has also been made towards the 2005 World Health Assembly target of a 75 percent reduction in the global burden of malaria by 2015.
Progress has resulted, in large part, from the massive deployment of effective and low-cost malaria control interventions. Since 2000, nearly 1 billion insecticide-treated mosquito nets have been distributed in sub-Saharan Africa. By 2015, about 55 percent of the population in this region was sleeping under mosquito nets, up from less than 2 percent coverage in 2000.
Rapid diagnostic tests have made it easier to swiftly distinguish between malarial and non-malarial fevers, enabling timely and appropriate treatment. A sharp increase in diagnostic testing for malaria has been reported in the WHO African Region: from 36 percent of suspected malaria cases in 2005 to 65 percent of cases in 2014. Artemisinin-based combination therapies (ACTs), introduced widely over the past decade, have been highly effective against P. falciparum, the most prevalent and lethal malaria parasite affecting humans.
An estimated 663 million cases of malaria have been averted in sub-Saharan Africa since 2001 as a direct result of the scale-up of three key malaria control interventions: insecticide-treated mosquito nets, indoor residual spraying and artemisinin-based combination therapy. Mosquito nets have had the greatest impact, accounting for about 68 percent of cases prevented through these interventions.
Despite progress, significant challenges remain. Globally, about 3.2 billion people-nearly half of the world’s population-are at risk of malaria. In 2015, there were estimated 214 million new cases of malaria, and approximately 438 000 deaths.
Fifteen countries, mainly in Africa, account for most global malaria cases (80 percent) and deaths (78 percent). According to the report, these high burden countries have achieved slower-than-average declines in malaria incidence (32%) compared to other countries globally (53 percent). In many of these countries, weak health systems continue to impede progress in malaria control.
Millions of people are still not receiving the services they need to prevent and treat malaria. In 2014, approximately one-third of people at risk of malaria in sub-Saharan Africa lived in households that lacked protection from mosquito nets or indoor residual spraying.
“As the global burden of malaria declines, new challenges have emerged,” says Dr. Pedro Alonso, director of the WHO Global Malaria Program. “In many countries, progress is threatened by the rapid development and spread of mosquito resistance to insecticides. Drug resistance could also jeopardize recent gains in malaria control.”
Since 2010, 60 of the 78 countries that monitor insecticide resistance have reported mosquito resistance to at least one insecticide used in nets and indoor spraying; of these, 49 reported resistance to two or more insecticide classes. Parasite resistance to artemisinin- the core compound of the best available antimalarial medicines-has been detected in five countries of the Greater Mekong subregion.
In May 2015, the World Health Assembly adopted the WHO "Global Technical Strategy for Malaria 2016-2030," a new 15-year framework for malaria control in all endemic countries. The strategy sets ambitious but achievable targets for 2030, including a reduction in global malaria incidence and mortality of at least 90 percent; the elimination of malaria in at least 35 countries; and the prevention of a resurgence of malaria in all countries that are malaria free.
Achieving these targets will require country leadership, sustained political commitment and a tripling of global investment for malaria control: from the $2.7 billion in annual funding available today to $8.7 billion in annual funding by 2030. This figure takes into account future savings in case management costs anticipated as malaria control efforts continue to expand and more cases are averted.
Source: WHO
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.